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Advance care planning for patients with advanced illnesses attending
hospital outpatient clinics study: A study protocol for a randomised
controlled trial
Abstract

Introduction It is unclear whether advance care planning (ACP) undertaken with patients living in the
community can improve patient care and avoid unwanted interventions and hospital admissions. We have
designed a randomised controlled trial (RCT) to examine if ACP undertaken with patients with advanced
illnesses attending hospital outpatient clinics can reduce unplanned hospital admissions and improve patient
and caregiver well-being.
Methods and analysis Pragmatic RCT involving patients from subspecialty outpatient clinics at five clinical
sites in Sydney, Australia. Participants will be ≥18 years screened as potentially having palliative care needs
and at risk of dying in 6-12 months. The patients will be randomised to intervention or control group.
Intervention group will undertake ACP discussions facilitated by a trained health professional. The control
group will receive written information on ACP, representing the current standard of care. The primary
outcome is the number of unplanned hospital admissions at the 6-month follow-up. Secondary outcomes
include: (i) patient's health-related quality-of-life and quality of chronic disease care; (ii) caregiver's healthrelated quality-of-life and caregiver burden and (iii) other health outcomes including ambulance usage,
emergency department presentations, hospital admissions, resuscitation attempts, intensive care unit
admissions, deaths, documentation of patient wishes in patient records and audit of ACP discussions and
documents. The staff 's self-reported attitudes and knowledge of ACP will also be measured. The data will be
collected using self-report questionnaires, hospital records audit, audit of ACP documentation and data
linkage analysis. Semistructured interviews and focus group discussions with patients, caregivers and
healthcare professionals will explore the acceptability and feasibility of the intervention.
Ethics and dissemination Approved by South-East Sydney Local Health District Human Research Ethics
Committee and NSW Population and Health Services Research Ethics Committee. Results will be
disseminated via conference presentations, journal publications, seminars and invited talks.
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Abstract
Introduction It is unclear whether advance care
planning (ACP) undertaken with patients living in the
community can improve patient care and avoid unwanted
interventions and hospital admissions. We have designed
a randomised controlled trial (RCT) to examine if ACP
undertaken with patients with advanced illnesses
attending hospital outpatient clinics can reduce unplanned
hospital admissions and improve patient and caregiver
well-being.
Methods and analysis Pragmatic RCT involving patients
from subspecialty outpatient clinics at five clinical sites in
Sydney, Australia. Participants will be ≥18 years screened
as potentially having palliative care needs and at risk of
dying in 6–12 months. The patients will be randomised
to intervention or control group. Intervention group will
undertake ACP discussions facilitated by a trained health
professional. The control group will receive written
information on ACP, representing the current standard of
care. The primary outcome is the number of unplanned
hospital admissions at the 6-month follow-up. Secondary
outcomes include: (i) patient’s health-related quality-oflife and quality of chronic disease care; (ii) caregiver’s
health-related quality-of-life and caregiver burden and
(iii) other health outcomes including ambulance usage,
emergency department presentations, hospital admissions,
resuscitation attempts, intensive care unit admissions,
deaths, documentation of patient wishes in patient records
and audit of ACP discussions and documents. The staff’s
self-reported attitudes and knowledge of ACP will also
be measured. The data will be collected using self-report
questionnaires, hospital records audit, audit of ACP
documentation and data linkage analysis. Semistructured
interviews and focus group discussions with patients,
caregivers and healthcare professionals will explore the
acceptability and feasibility of the intervention.
Ethics and dissemination Approved by South-East
Sydney Local Health District Human Research Ethics
Committee and NSW Population and Health Services
Research Ethics Committee. Results will be disseminated
via conference presentations, journal publications,
seminars and invited talks.
Trial registration number ACTRN12617000280303.

Strengths and limitations of this study
►► Due to its design as a pragmatic randomised con-

trolled trial in real-world conditions, the findings of
the study are likely to be generalisable to clinical
practice.
►► Multiple sources of data including surveys of participants, audit of medical records, health outcomes
data obtained through data linkage and qualitative
data (focus groups and interviews) will allow the
study to examine the effectiveness of the intervention on health outcomes, patient reported outcomes
as well as its impact on health professionals and
clinical services.
►► The multiple sources of data will also allow triangulation of the findings, especially health outcomes.
►► The sample size takes into account the significant
drop-out rate expected in the study due to withdrawal and/or loss to follow-up and high mortality
expected in the study patient population.

Introduction
Advance care planning (ACP) is a process
of reflection, discussion and communication that enables a person to plan for their
future medical treatment and other care
for a time when they are not competent to
make, or communicate, decisions for themselves.1 2 ACP can significantly improve the
quality of care provided to patients with
advanced illnesses,3 increase the chance of
patient’s wishes being known and followed,
improve emotional outcomes for the patient
and caregivers and increase caregiver satisfaction.4 5 There is also some evidence that ACP
improves the patient’s quality of life,5 reduces
ambulance use and unplanned hospital
admissions6 7 and contributes to reduced
patient mortality.6
The importance of ACP in patient care has
been widely recognised and endorsed by a
large number of professional groups, specialist
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Objective
The objective of this study is to determine whether a
model of facilitated ACP intervention based in hospital
outpatient clinics will reduce unplanned hospital admissions and acute health services usage, improve the quality
of care for patients and their caregivers/family and result
in improved understanding and uptake of ACP by health
professionals.
Methods and analysis
Study design and setting
This study is a pragmatic, prospective, multisite
randomised controlled trial (RCT) with two parallel
groups. It is a pragmatic RCT testing the real-world
effectiveness of a complex intervention aimed at embedding ACP into routine care provided by hospital outpatient clinics. The study setting is subspecialty outpatient
clinics (renal, cardiac, liver, respiratory, aged care and
2

other relevant clinics) at five clinical sites across two
Local Health Districts (LHDs) in Sydney, Australia: South
East Sydney LHD (Prince of Wales Hospital, Sutherland
Hospital, St George Hospital, War Memorial Hospital)
and Sydney LHD (Concord Hospital).
Participants
To be eligible for the study, patients must be 18 years or
older and attend an outpatient clinic of participating
clinical services. They must be identified as potentially
having supportive and palliative care needs and be at
potential risk of dying in the next 6–12 months, as determined by the Supportive and Palliative Care Indicators
Tool (SPICT).16 Patients must be interested in engaging
in ACP as determined by the ACP screening tool17 and
be willing and able to give written informed consent. If
SPICT reveals that the patient has dementia or other
illnesses that may impact on the patient’s decision-making
capacity, then the treating medical team will determine
if they have the capacity to provide informed consent.
If they do not, then consent will be obtained from the
person responsible (substitute decision-maker according
to the hierarchy as defined by the NSW Guardianship Act
1987), together with the patient.
Patients are not eligible for the trial if they are younger
than 18 years of age, are pregnant or have both appointed
an enduring guardian and made an advance care directive (ACD)/plan as determined by the ACP screening
tool.17 Current inpatients or permanent residents of a residential aged care facility will be excluded from the study.
Patients (or if a patient lacks decision making capacity,
his/her guardian or person responsible) who are unable
or unwilling to provide informed consent or are unable
to provide informed consent and participate in ACP
conducted in English due to difficulties in understanding
and speaking English, also will be excluded. Figure 1
describes the participant assessment and follow-up plan.
Intervention and control
Patients randomised to the control group will be provided
written information on ACP, which represents the current
standard care. The written information consists of: (1)
ACP brochure produced by NSW Health,18 which contains
basic information about ACP and where to get assistance if interested; (2) ACP workbook endorsed by NSW
Health;19 (3) Enduring Guardianship NSW booklet20
and (4) Statement of Values and Wishes completed on
behalf of the patient by their person responsible, when
the patient is unable to develop an ACD.
The intervention group will be provided the same
written information on ACP as the control group; however,
ACP discussions will be actively facilitated by an ACP coordinator or other trained health professional (table 1).
This includes discussions with patients, caregivers, family
and clinical staff, communications with other specialists,
general practitioners (GPs) and other health providers
involved in patient care, assistance with completing documentation and assistance with dissemination of ACP
Rhee J, et al. BMJ Open 2019;9:e023107. doi:10.1136/bmjopen-2018-023107
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colleges, peak bodies and patient advocate groups and in
diverse clinical populations.8 In Australia, the National
Health and Hospitals Reform Commission9 established
by the Federal Government identified the importance of
ACP and recommended its implementation on a national
scale. The New South Wales (NSW) Ministry of Health
created a policy on ACP;10 its priority is to incorporate
ACP into routine care, to educate health professionals in
both conducting and responding to ACP and to improve
collaboration between NSW clinical services and community and primary care health professionals.
Despite the wide recognition and endorsement, ACP
is not commonly done in Australia.11 A chart audit
conducted in 2006 in a large tertiary teaching hospital
in Australia showed that none of 47 consecutive patients
whose treatment was withdrawn in the intensive care unit
had evidence of ACP.12 An older retrospective chart audit
of 110 patients older than 65 years of age who died in a
Sydney hospital showed the prevalence of Advance Care
Plans (unclear but presumably informal documents) of
7.3%.13 Studies from other Australian jurisdictions do not
provide additional insights into the prevalence of ACP,
except that it is very uncommon.1 14
Current evidence that ACP may lead to reduction in
ambulance use and hospital admissions exists mainly in
the residential aged care home setting.6 There is a lack
of studies in Australia conducted in the community or
outpatient settings, which examine the effect of ACP
on unplanned hospital admissions or the use of acute
health services. Busy emergency departments (EDs) and
hospital wards are not ideal settings for ACP, and there is
evidence that ACP decisions made when acutely unwell
differ from decisions made when medically stable, so
outpatient clinics are a better setting in which to conduct
ACP.15 There is, however, lack of training and support for
staff working in outpatient clinics to first identify patients
who may benefit from ACP and second to facilitate ACP.

Open access

Participant assessment and follow-up plan. ACP, advance care planning.

documents, such as uploading them to the hospital electronic medical record system. The model of ACP used in
the study has been in active clinical use for many years at
several hospital sites that are taking part in the current
study. It has been refined through active clinical practice,
is approved by the hospital management and is widely
accepted by the clinicians and patients.
Registered nurses from aged care, palliative care and
chronic disease management background with interest
and expertise in care coordination and ACP have been
recruited as ACP coordinators for the project. They
received face-to-face training in ACP and will be supervised by a Chief Investigator (AM) who is an expert in
ACP and has conducted many training workshops. The
three ACP coordinators will work closely with the staff of
the participating outpatient clinics and will be responsible
for initiating and conducting ACP discussions, answering
questions from patients, caregivers and staff and assisting
the patients with completion of ACDs and other documents. They will organise and facilitate meetings and
Rhee J, et al. BMJ Open 2019;9:e023107. doi:10.1136/bmjopen-2018-023107

teleconferences with clinical staff (eg, specialists and
GPs) involved in the care of the patient and assist with
dissemination of the completed documents using the
hospital electronic medical records system and to GPs
and specialists. The ACP coordinators will also provide
education, training and mentorship to clinic staff, GPs
and other health providers and help them incorporate
ACP into routine care. The ACP coordinators will not
have any other involvement in patient care.
Clinical staff ACP training
The clinical staff (medical, nursing, allied health)
working in the participating outpatient clinics will receive
education and training in ACP through lunchtime seminars, workshops or unit meetings run by members of the
research team and the project ACP coordinators. The
training will use existing resources, such as Planning Ahead
website (http://planningaheadtools.com.au/), NSW
Health endorsed ACP booklet,18 NSW Health documents
and directives, such as the Using Resuscitation Plans in End
3
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Figure 1
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Intervention group (facilitated ACP)
Written information on ACP:

Control group (current standard care)
18

►► ACP brochure produced by NSW Health
19
►► ACP workbook endorsed by NSW Health
►► Enduring Guardianship NSW booklet produced by the

Written information on ACP:

18

►► ACP brochure produced by NSW Health
19
►► ACP workbook endorsed by NSW Health
►► Enduring Guardianship NSW booklet produced by the

Public Guardian Office of the NSW Government Department
Public Guardian Office of the NSW Government Department
of Attorney General & Justice20
of Attorney General & Justice20
►► Statement of Values and Wishes completed on behalf of
►► Statement of Values and Wishes and supplemental
the patient by their person responsible (when the person is
information for families used for families to develop a plan
unable to develop an ACD) and supplemental information
(when the person is unable to develop an ACD)
for families
Procedures, activities, processes delivered by ACP
coordinators or ACP trained outpatient clinics staff:
►► Provision of personalised information on ACP
►► Facilitation of ACP discussions with patients, caregivers,
family and relevant health professionals
►► Assistance in completing appropriate ACP documents
►► Referral to relevant local legal services for witnessing as
required
►► Organising and facilitating meetings and/or teleconferences
with clinic staff, GPs and other healthcare professionals
involved in patient’s care to discuss the patient’s care and
their wishes
►► Assistance with dissemination of ACP documents on
completion that may include upload to LHD record system,
national eHealth record (contingent on LHD and national
eHealth improvements during the study period) and
forwarding the document to patient’s GP
ACP, advance care planning; LHD, Local Health District; NSW, New South Wales; RCT, randomised controlled trial.

of Life Decisions document,21 and Health Education and
Training Institute (HETI) training modules. Additional
topics covered in the training will include legal liability
and protection offered by Advance Care Plans and ACDs,
capacity determination and hierarchy of decision-making
in NSW.
Both the clinical staff training and the facilitated ACP
intervention are informed by the Diffusion of Innovation
Theory.22 This theory states that five conditions need to
be met for innovation to be taken up: relative advantage,
compatibility, complexity (how difficult the innovation
appears), trialability and observability (whether positive
outcomes of the innovation can be observed). This means
that didactic education sessions alone are unlikely to be
sufficient to lead to significant increase in ACP undertaken by health professionals. For instance, compatibility
with clinical service workflow or positive impact of ACP
may not be readily apparent to busy clinicians, until
they have experienced first-hand, ACP done with their
patients. The study intervention allows staff members
of clinical services to ‘see’ a few and ‘do’ a few, thereby
increasing the chance of ACP being embedded into the
routine care of patients.
Clinic staff will be initially invited to join ACP sessions
facilitated by ACP coordinators (ie, ‘see’) in their clinical
role (eg, as a doctor or nurse participant). After a few
observations, clinic staff will be invited to facilitate ACP
4

discussions (ie, ‘do’) with ACP coordinators observing
and providing support. And finally, the clinic staff will
conduct sessions independently with ACP coordinators
providing telephone and email support. The precise
details of how many clinic staff members undertake ‘see’
and ‘do’ will vary from clinic to clinic according to their
staffing levels and available resources.
In addition, the research team will facilitate educational sessions for local GPs and other health professionals providing care for the patients enrolled in the
study, in conjunction with the Central and Eastern Sydney
Primary Health Network, an important partner in the
study. ACP coordinators will also use their interactions
with the patient’s GP or other health providers involved
in the patient’s care as opportunities to promote ACP
and for education. For instance, when they fax a copy of
the patient’s ACD to the GP, this will be accompanied by
an information sheet on ACP and the web address of the
Planning Ahead website (http://planningaheadtools.com.
au).
Participant recruitment and enrolment
The outpatient clinic staff, either independently or with
assistance from the ACP coordinators, will apply the
SPICT16 to the patients attending the clinic that day.
Having two or more general indicators, or one or more
specific clinical indicators, will be taken as satisfying the
Rhee J, et al. BMJ Open 2019;9:e023107. doi:10.1136/bmjopen-2018-023107
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Table 1 Elements of ACP interventions in RCT
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Primary outcome
The primary outcome is the number of unplanned
hospital admissions, defined as admissions or readmissions with an overnight stay that were not previously
planned or scheduled or ‘elective’,23 during the 6-month
follow-up period. The data will be collected via an audit of
the hospital records after the 6-month follow-up period.
Secondary outcomes
Several secondary outcomes will be assessed at the
6-month follow-up. The data will be collected using self-report questionnaires, audit of hospital records, audit of
ACP documentation and data linkage analysis (table 2).
Secondary outcomes assessed via self-reported surveys:
►► Patient’s health related quality of life (SF-20).
►► Patient’s reported quality of chronic disease care
(PACIC).
►► Caregiver’s health related quality of life (SF-20).
►► Primary caregiver burden (ZBI-12).
►► Clinical staff’s knowledge and attitudes to ACP.
Secondary outcomes measured using hospital records
audits:
►► Hospital admissions (unplanned and planned).
►► ED presentations.
►► Cardiopulmonary resuscitation (CPR) attempts.
Rhee J, et al. BMJ Open 2019;9:e023107. doi:10.1136/bmjopen-2018-023107

Documentation of ACDs and patient wishes in patient
records.
Secondary outcomes measured using data linkage
analysis:
►► Ambulance services calls.
►► ED presentations.
►► Total number of hospital admissions.
►► Date, place and causes of death.
►► Resuscitation attempts.
►► Intensive care unit admissions.
►►

Data collection and follow-up
Screening
Patient’s suitability for participation in the RCT will be
assessed using the SPICT16 and the ACP Screening Interview adapted from an original interview developed by
Cheang et al.17 SPICT is a widely used tool that allows health
and social care professionals to identify patients with
advanced illnesses, who are potentially having supportive
and palliative care needs and are at higher risk of death
in the next 6–12 months. SPICT has six general indicators of deteriorating health and clinical signs of advanced
illnesses, such as congestive cardiac failure, chronic
advanced respiratory illness that causes dyspnoea at rest or
requires home oxygen, end stage renal failure, especially
where dialysis has been stopped, advanced cirrhosis with
complications such as hepatorenal syndrome and frailty.
The modified version of the ACP Screening Interview will
be used to determine whether patients have already been
involved in ACP and if they have not, then whether they
are interested in engaging in ACP.
Baseline data collection
The baseline enrolment questionnaire includes the
patient’s basic demographic information including age,
gender, marital status, employment status, country of
birth, language spoken at home, Aboriginal or Torres
Strait Islander heritage, level of education and whether
they had a regular general practitioner. The patient’s
caregiver will provide their own basic demographics data
(age, gender, marital status, employment status, country
of birth, language spoken at home, Aboriginal or Torres
Strait Islander heritage and level of education) and the
number of hours per week spent on caregiving duties.
The clinic staff member will complete the Charlson
Comorbidity Index (CCI)24 for the patient. The CCI is a
validated measure of 1-year mortality risk and burden of
disease, feasible in various healthcare settings. It consists
of 17 comorbidities, including two subcategories for
diabetes and liver disease, which are weighted from 1 to 6
for mortality risk and disease severity and summed to the
total CCI score.
Also at baseline as well as at the 6-month follow-up,
self-report patient data will be collected on the health-related quality of life using the 20-Item Short Form Health
Survey (SF-20)25 26 and the quality of chronic disease
care using the Patient Assessment of Chronic Illness
Care (PACIC).27 The SF-20 is a validated measure of
5
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SPICT criteria. Patients identified as meeting the SPICT
criteria will be handed a 1-page brochure with information about the project by the clinic staff on their arrival to
the clinic appointment, unless the treating clinical team
felt that it would be inappropriate to invite them to the
study. Those expressing an interest in the study will be
invited to meet with the ACP coordinator who will administer the ACP screening tool17 to assess whether a patient
had previously been involved in ACP and if not then
whether they are interested in engaging in ACP. Patients
who had not been involved in ACP and were interested in
ACP will be provided with further information about the
study and invited to provide written informed consent.
The ACP coordinator will check the inclusion and exclusion criteria to make sure that the patient was eligible to
participate in the trial. If SPICT reveals that the patient has
dementia or other illness that may impact on the patient’s
decision-making capacity, the treating medical team will
be asked to determine if the patient has sufficient decision-making capacity to provide informed consent. If they
do not, the person responsible will be invited to provide
informed consent.
A participant will be enrolled into the study after the
informed consent has been obtained and if the participant meets all inclusion criteria and does not meet any of
the exclusion criteria. The participant will then complete
a baseline patient questionnaire and nominate a caregiver
to complete a baseline caregiver questionnaire. Following
the completion of the enrolment questionnaires, the
patient will be randomised to a control or intervention
group.

Open access

Outcome/variable

Measurement tool/data
source

Validated

Screener

Patients
 Supportive/palliative care needs

SPICT

✓

✓

 Previous ACP

ACP Screening Tool

 Contact information

Purpose designed
questionnaire

✓

 Demographics

Purpose designed
questionnaire

✓

 Comorbidity

CCI

✓

✓

 Health related quality of life

SF-20

✓

✓

✓

 Assessment of care for chronic
conditions

PACIC

✓

✓

✓

 ACP discussion sessions*

Audit of ACP discussion
sessions*

✓

 ACP in the patient records

Audit of hospital records

✓

 Hospital/ED admissions

Audit of hospital records;
data linkage

✓

 Ambulance service utilisations

Data linkage

✓

 Health services utilisation

Data linkage

✓

 Deaths

Data linkage

✓

Baseline

6 months

✓

Caregiver
 Contact information

Purpose designed
questionnaire

✓

 Demographics

Purpose designed
questionnaire

✓

 Health related quality of life

SF-20

✓

✓

✓

 Caregiver burden

ZBI-12

✓

✓

✓

Clinical staff
 Contact information

Purpose designed
questionnaire

✓

 Demographics

Purpose designed
questionnaire
Staff survey

✓

 ACP attitudes, knowledge,
confidence

✓

✓

✓

*Intervention group only; CCI: Charlson Comorbidity Index;23 PACIC: Patient Assessment of Chronic Illness Care;26 SF-20: 20-Item Short
Form Health Survey;24 25 SPICT: Supportive and Palliative Care Indicators Tool;15 ZBI-12: Zarit Burden Short Form Interview.27
ACP, advance care planning; ED, emergency department.

multiple health dimensions: physical functioning, role
functioning, social functioning, mental health, perceptions of current health and pain. The SF-20 scores are
transformed linearly to 0–100 scales, where 0 is the lowest
possible score and 100, the highest possible score. The
PACIC is a validated 20-item instrument to assess chronic
illness patient’s experience in five domains of care:
patient activation, delivery system design, goal setting,
problem solving and follow-up/coordination. The score
is obtained by summing participants’ responses across all
20 items on a 5-point Likert scale, divided by 20. PACIC
total scores range from 1 to 5; higher scores indicate
6

patient’s perception of greater involvement in self-management and chronic care counselling.
Caregivers of patients will be asked to complete a
self-report questionnaire focusing on their quality of
life (SF-20) and caregiver burden (ZBI-12),28 at baseline
and at the 6-month follow-up. The ZBI-12 is a validated
instrument to provide brief and accurate assessment of
caregiver burden. Each ZBI-12 item is a statement to be
endorsed on a 5-point Likert scale (0—never, 4—nearly
always); a higher score indicates a higher level of caregiver burden.
Rhee J, et al. BMJ Open 2019;9:e023107. doi:10.1136/bmjopen-2018-023107
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Table 2 Study outcomes/variables, measurement tools and data collection schedule
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6-month data collection
At the 6-month follow-up, self-report patient data will be
collected on the health-related quality of life (SF-20)25 26
and the quality of chronic disease care (PACIC).27 Caregivers of patients will be asked to complete a self-report
questionnaire focusing on their quality of life (SF-20) and
caregiver burden (ZBI-12).28 Clinical staff working in the
outpatient clinics and participating in the ACP training
will complete a 6-month follow-up survey on ACP knowledge and attitudes.29
The 6-month follow-up involves an audit of ACDs
(both intervention and control group) and an audit of
ACP discussion sessions (intervention group only). The
audit of ACD measures the output of ACP as indicated by
the number and types of documents created as a result
of ACP discussions. The audit of ACP discussion sessions
involves collection of data on time taken; number of
attendees and their categories (eg, patient, facilitator,
family member, other healthcare professionals); number
and types of documents completed; number and types
of documents distributed; recommendations made to
appoint substitute decision makers and referrals made to
legal and specialist services.
The 6-month follow-up hospital records audits will
collect data on planned and unplanned hospital admissions, ED presentations, admission into the intensive care
unit, cardiopulmonary resuscitation, major procedures
and investigations, documentation of ACDs and patient
wishes in patient records. Additionally, the following
information will be collected through data linkage in
collaboration with the Centre for Health Record Linkage
(CHeReL): (1) ambulance services calls assessed by data
linkage to NSW Ambulance Data Collection, (2) ED
presentations assessed by data linkage to NSW Emergency
Department Data Collection, (3) total number of hospital
admissions assessed by data linkage to NSW Admitted
Patient Data Collection, (4) date, place and causes of
death assessed by data linkage NSW Mortality Data, 5)
resuscitation attempts assessed by data linkage to NSW
Emergency Department Data Collection, NSW Admitted
Patient Data Collection, NSW Ambulance Data Collection and (6) Intensive Care Unit admissions assessed by
data linkage to NSW Admitted Patient Data Collection.
Rhee J, et al. BMJ Open 2019;9:e023107. doi:10.1136/bmjopen-2018-023107

At the 6-months mark, a small number of participants
including patients, caregivers and healthcare professionals, will be invited to participate in semistructured
interviews and focus groups. The interviews and focus
groups will explore the acceptability and feasibility of the
facilitated ACP process for patients, caregivers and clinical staff. The study will also evaluate the ACD form and
the accompanying information booklet used in the study.
This evaluation will canvass the views of patients, their
caregivers and health professionals about the usefulness
and appropriateness of these documents as well as their
recommendations for improving the template.
Sample size
The sample size calculation is based on an assumed alpha
of 0.05, power of 0.8 to detect at least 25% reduction (IRR
0.75) in unplanned hospital admissions over 6 months
(from an average of 2.2 over 6 months to 1.65 admissions
over 6 months assuming the number of admissions follows a
Poisson distribution in each group). Based on these assumptions, the study needs to recruit 100 people in each group,
who will have the full 6-month follow-up, so that the number
of hospitalisations in the groups are 220 (control) and 165
(intervention). However, given that the expected death rate
in the 6 months of the trial is up to 35%, the study needs to
recruit 122 people in each arm of the trial. If the expected
drop-out rate (withdrawal, loss to follow-up) is 15%, 144
people are needed in each arm of the trial (in total n=288).
The estimated mean numbers of hospital admissions were
obtained from a study conducted in Scotland16 which showed
that patients with advanced renal, liver, cardiac and respiratory conditions identified by SPICT as at risk of dying within
12 months had high hospital unplanned admission rates in
the next 6 months (for patients alive, mean 2.2 admissions in
6 months; for patients who have died, mean 2.4 admissions
in last 6 months of life). This study also showed a death rate
of 35% over a 6-month period. Effect size estimates for ACP
in reducing admissions are based on a study by Caplan et al,6
which showed that patients from nursing homes that had
ACP programme had relative risk of hospital admission of
0.74 compared with control homes. Molloy et al7 conducted
a cluster RCT in Canadian nursing homes that showed that
patients in nursing homes with ACP had mean admission
rate of 0.27 per resident, compared with 0.48 for control
homes over 18-month period. The effect size estimate of at
least 25% reduction in admissions over 6 months is reasonable when compared with these figures.
Randomisation
Prior to randomisation, the patient participants are required
to meet all the inclusion criteria and do not meet any of the
exclusion criteria, screened using the ACP screening tool,
provide written informed consent and complete the baseline
questionnaire. Patients are randomised to either intervention or control group using an online randomisation service
(randomize.net). Randomisation is at the individual level
by a computer generated random number sequence, in
blocks of random sizes (4 and 6), in 1:1 ratio (control and
7
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Clinical staff working in the outpatient clinics and
participating in the ACP training will complete presurveys and postsurveys on ACP knowledge and attitudes.
The survey consists of nine ACP knowledge items and
nine items measuring beliefs, attitudes, experiences and
perceived confidence and willingness of clinical staff to
conduct ACP. The survey items were designed by a registered nurse and a GP with expertise in ACP and primary
palliative care and tested in a study looking at ACP confidence levels and motivation in practice nurses in a GP
setting.29 The knowledge questions involve ‘yes/no’
questions and multiple choice questions and the attitude
items are based on a five-point Likert scale with levels of
agreement ranging ‘strongly disagree’ to ‘strongly agree’.
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Data analysis
Quantitative data
Descriptive statistics will be presented as proportions or
means, with SD. Statistically significant difference in means
between the intervention and control groups for continuous
variables will be analysed using tests such as student’s t-test
and analysis of variance. χ² and similar tests will be used to
test statistical significance of categorical variables. Multivariate regression will be used to analyse the impact that
independent variables may have on primary and secondary
outcomes.
For the primary outcome (ie, number of unplanned
hospital admissions during at 6-month follow-up), a Poisson
regression model will be fitted, including follow-up time as an
offset to compare the mean number of admissions between
the trial arms. The analysis will also adjust for the variables
used in stratification in the randomisation (number of
admissions in 6 months prior to the trial and the study site).
Secondary outcomes at 6 months, such as ambulance service
calls, ED presentations, hospital admissions and other patient
outcomes, will be analysed similarly to the primary outcome.
Linear regression adjusting for stratification variables will be
used to analyse other secondary outcomes at 6 months, such
as health related quality of life, caregiver burden and assessment of quality of chronic disease care. Descriptive statistics will be used to analyse frequency of documentation of
patient wishes in patient records, in the audit of SPICT, ACP
screening tool forms completed by clinic staff and the ACDs
and advance care plans completed during the study. Analysis
of the results will be based on the initial group allocation,
regardless of whether the intervention has been delivered
in intervention participants or in the case of control group
participants, whether they have engaged in ACP.
Patient and public involvement
The development of the research question and outcome
measures was informed by the findings of the literature
outlining the potential benefits that ACP can have on
patients and caregivers. The study therefore includes
multiple patient reported outcome measures as well as
similar measures for the caregivers as well as a qualitative
substudy to capture the experience of the patients and
caregivers of being in the intervention and the control
group.
Representatives from consumer organisations and
patient advocacy groups are actively involved in the study
8

steering group and have provided input into the study
design and the conduct of the study.
A summary of the study findings will be provided to the
study participants.
Ethics and dissemination
Ethics approval was obtained from the SESLHD Human
Research Ethics Committee (HREC/16/POWH/654)
and the NSW Population & Health Services Research
Ethics Committee (2017/HRE1103). The trial has been
registered with the Australian and New Zealand Clinical
Trials Registry (Trial ID: ACTRN12617000280303). The
study was approved by the NSW Population and Health
Service Research Ethics Committee (2017/HRE1103)
for the use of linked data owned or managed by NSW
Ministry of Health, including the NSW Admitted Patient
Data Collection and the NSW Emergency Department
Data Collection.
Study results will be disseminated via reports to the
funding body, academic presentations at conferences,
journal publications and seminar sessions, workshops and
invited talks.
Discussion
The current study has been designed to determine whether
a model of facilitated ACP intervention for patients with
advanced illnesses attending hospital outpatient clinics can
reduce unplanned hospital admissions and acute health
services usage and improve the quality of care for patients
and their caregivers/family. This study has several strengths
and limitations which are presented below.
Strengths
This RCT has a number of potential benefits. It may provide
high-level (RCT) evidence that ACP conducted outside of the
residential care home setting can lead to reduced unplanned
hospital admissions and acute health services usage. Importantly, it could provide evidence that this can be achieved
while at the same time improving patient quality of life, satisfaction with care and reducing caregiver burden. Further,
the proposed model of ACP has the potential to incorporate
ACP into routine care of patients with advanced illnesses in
outpatient clinics and by other health professionals involved
in their care. This will be done by a process of diffusion,
for instance, clinic staff are initially invited as participants
in ACP discussions facilitated by trained ACP coordinators
and as they gain experience and receive training and education, they facilitate ACP independently. The delivery of the
facilitated ACP intervention requires ongoing involvement
of skilled clinical staff in a busy everyday clinical practice.
Training and support, informed by the Diffusion of Innovation Theory and provided in the study by the ACP coordinators in clinical settings, should ensure quality and fidelity of
the delivered intervention.
Limitations
Significant drop-out rate due to withdrawal and/or loss
to follow-up, and high mortality, is to be expected in an
Rhee J, et al. BMJ Open 2019;9:e023107. doi:10.1136/bmjopen-2018-023107
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intervention). Stratification is according to the study site
(hospital) and the number of hospital admissions in the past
6 months (<2 vs 2 or more).
Study conducted by Highet et al16 showed significant
differences in unplanned admission rates and death rates
in patients who had <2 admissions in the 6 months prior to
the study period compared with those who had 2 or more
admissions. Due to the nature of the intervention, it is not
possible to blind the patients participating in the study and
clinical staff providing the ACP intervention, including ACP
coordinators.
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Trial status
Recruitment for the study commenced in April 2017 and
was completed in December 2017. The interventions were
conducted between May 2017 and December 2017. The
6-month follow-up (patient and caregiver questionnaires,
audits) is expected to be completed by July 2018, with the
data linkage extraction and analysis taking place in late 2018.
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intervention study of patients with advanced illnesses. This
limitation has been taken into account in the calculation
of an adequate sample size. In addition, the study excludes
people whose English language skills are not adequate as
documents were only available in English.

